The role of Spred1 and the Ras/MAPK pathway in sepsis

被引：0
|
作者：
Morgner, S. [1 ]
Naeem, Z. [2 ]
Krueger, T. [3 ]
Kniemeyer, O. [3 ]
Biskup, C. [4 ]
Rubio, I [1 ]
机构：
[1] Jena Univ Hosp, Dept Anesthesiol & Intens Care Med, Expt Anesthesiol, Jena, Germany
[2] CMB, Inst Mol Cell Biol, Jena, Germany
[3] Hans Knoll Inst HKI Jena, Leibniz Inst Nat Prod Res & Infect Biol, Mol & Appl Microbiol, Jena, Germany
[4] Jena Univ Hosp, Biomol Photon, Jena, Germany
来源：
INFECTION | 2019年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
050
引用
收藏
页码：S15 / S15
页数：1
相关论文
共 50 条
  • [1] Merlin cooperates with neurofibromin and Spred1 to suppress the Ras-Erk pathway
    Cui, Yan
    Ma, Lin
    Schacke, Stephan
    Yin, Jiani C.
    Hsueh, Yi-Ping
    Jin, Hongchuan
    Morrison, Helen
    HUMAN MOLECULAR GENETICS, 2020, 29 (23) : 3793 - 3806
  • [2] SPRED1, a RAS MAPK pathway inhibitor that causes Legius syndrome, is a tumour suppressor downregulated in paediatric acute myeloblastic leukaemia
    E Pasmant
    B Gilbert-Dussardier
    A Petit
    B de Laval
    A Luscan
    A Gruber
    H Lapillonne
    C Deswarte
    P Goussard
    I Laurendeau
    B Uzan
    F Pflumio
    F Brizard
    P Vabres
    I Naguibvena
    S Fasola
    F Millot
    F Porteu
    D Vidaud
    J Landman-Parker
    P Ballerini
    Oncogene, 2015, 34 : 631 - 638
  • [3] SPRED1, a RAS MAPK pathway inhibitor that causes Legius syndrome, is a tumour suppressor downregulated in paediatric acute myeloblastic leukaemia
    Pasmant, E.
    Gilbert-Dussardier, B.
    Petit, A.
    de Laval, B.
    Luscan, A.
    Gruber, A.
    Lapillonne, H.
    Deswarte, C.
    Goussard, P.
    Laurendeau, I.
    Uzan, B.
    Pflumio, F.
    Brizard, F.
    Vabres, P.
    Naguibneva, I.
    Fasola, S.
    Millot, F.
    Porteu, F.
    Vidaud, D.
    Landman-Parker, J.
    Ballerini, P.
    ONCOGENE, 2015, 34 (05) : 631 - 638
  • [4] Oncogenic RTK signaling inhibits Spred1/NF1 to sustain constitutive Ras/MAPK signaling
    Markegard, Evan
    Mercado, Ellen L.
    Castel, Pau
    Silva, Jillian
    Galeas, Jacqueline
    Li, Kathy
    Urisman, Anatoly
    McCormick, Frank
    CANCER RESEARCH, 2018, 78 (13)
  • [5] SPRED1 deletion confers resistance to MAPK inhibition in melanoma
    Ablain, Julien
    Liu, Sixue
    Moriceau, Gatien
    Lo, Roger S.
    Zon, Leonard, I
    JOURNAL OF EXPERIMENTAL MEDICINE, 2021, 218 (03):
  • [6] Role of SPRED1 in keratinocyte proliferation in psoriasis
    Li, Xinhua
    Li, Junqin
    Lu, Funa
    Cao, Yue
    Xing, Jianxiao
    Li, Juan
    Hou, Ruixia
    Yin, Guohua
    Zhang, Kaiming
    JOURNAL OF DERMATOLOGY, 2020, 47 (07): : 735 - 742
  • [7] EGFR-mediated Spred1 phosphorylation inhibits NF1 to sustain constitutive Ras/MAPK signaling
    Markegard, Evan
    Mercado, Ellen L.
    Silva, Jillian M.
    Galeas, Jacqueline
    Trinidad, Marena I.
    Urisman, Anatoly
    McCormick, Frank
    CANCER RESEARCH, 2017, 77
  • [8] Absence of Spred1, a negative regulator of Ras/MAPK pathway, as a mechanism responsible for the constitutive activation of RTK mediated signalling in acute leukemias.
    Cilloni, D
    Bracco, E
    Defilippi, I
    Messa, F
    Carturan, S
    Di Giovanni, D
    Arruga, F
    Rosso, V
    Catalano, R
    Messa, E
    Morotti, A
    Serra, A
    Saglio, G
    BLOOD, 2005, 106 (11) : 644A - 644A
  • [9] SPRED1 Interferes with K-ras but Not H-ras Membrane Anchorage and Signaling
    Siljamaki, Elina
    Abankwa, Daniel
    MOLECULAR AND CELLULAR BIOLOGY, 2016, 36 (20) : 2612 - 2625
  • [10] Spred1 and neurofibromin interact to negatively regulate Ras/Raf /MEK/ERK signaling
    Stowe, Irma B.
    Stowe, Timothy
    McCormick, Frank
    Mercado, Ellen
    CANCER RESEARCH, 2012, 72
12345